Protein Expression Market

Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), and Genscript Biotech Corporation (US) are the leading players in the Protein Expression Market

The global protein expression market size is projected to reach USD 4.1 billion by 2025 from USD 2.2 billion in 2020, at a CAGR of 13.2% between 2020 and 2025. The increasing incidence of chronic diseases, growth in the geriatric population, and increasing demand for protein biologics are the significant factors driving the growth of the protein expression industry. Emerging economies are likely to create substantial growth opportunities for players in the market. However, the high cost of protein expression reagents and instruments, along with increasing consolidation and high barriers for new entrants, will challenge market growth.

Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), and Genscript Biotech Corporation (US) are the key players operating in this market. Other prominent players are Takara Bio, Inc. (Japan), Bio-Rad Laboratories (US), Lonza (US), Promega Corporation (US), New England Biolabs (US), Oxford Expression Technologies Ltd. (US), and Synthetic Genomics Inc. (US).

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific Inc. is the largest player in the protein expression market. The large share of this company can be attributed to its robust suite of expression vectors, reagents, competent cells, and instruments. Owing to its strong sales and distribution network, the company has a significant global footprint. Additionally, the large number of production sites give it a competitive advantage over other players in the protein expression market. The company focuses on product launches to create a strong foothold in the market. In 2018, Thermo Fisher Scientific Inc. launched the Gibco ExpiSf System, the first-ever chemically defined protein expression system. The company further intends to strengthen its presence in this market by investing in R&D. Its extensive R&D activities enable it to increase its depth of capabilities in protein expression solutions and services and to provide innovative products and services in the market space.

In 2019, Merck KGaA was the second-largest player in the protein expression market. Merck has a diversified range of protein expression systems, such as algal-based expression systems, mammalian cell expression systems, prokaryotic expression systems, yeast cell expression systems, and insect cell expression systems. Moreover, the company also offers a range of expression vectors, reagents, and competent cells for the protein expression market. The company runs several long-term fundamental research programs in biology and chemistry as well as research programs directed toward product development. The company’s research and development model is designed to increase productivity and improve the probability of success by prioritizing projects which will lead to innovations in the pharmaceutical industry.

Related Reports:

Protein Expression Market by Type (Escherichia Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus and Cell-free), Products (Reagents, Competent Cells, Instruments, Services), Application, End-User and Region - Global Forecast to 2025

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Protein Expression Market Size,  Share & Growth Report
Report Code
BT 2435
RI Published ON
Choose License Type

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2022 MarketsandMarkets Research Private Ltd. All rights reserved Protection Status